Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
human umbilical cord mesenchymal stem cell preparation (Shanghai Life Science & Technology)
- Development stage
- Preclinical
- Lead developer
- Shanghai Life Science & Technology
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Intravenous, Intraperitoneal, Intrathecal, Local, Intrapancreatic, Intra-arterial, Topical
01
Overview
Human umbilical cord mesenchymal stem cell preparation is a cell therapy product developed by Shanghai Life Science & Technology (莱馥生命科技). It consists of mesenchymal stem cells (MSCs) harvested from human umbilical cord tissue. These cells are characterized by their ability to self-renew and differentiate into various cell types, as well as their potent immunomodulatory and anti-inflammatory properties. The preparation is currently being evaluated in investigator-initiated trials (IIT) for the treatment of several inflammatory and fibrotic conditions, including idiopathic pulmonary fibrosis (IPF), interstitial lung disease (ILD), inflammatory bowel disease (IBD), and diabetic nephropathy. The therapeutic mechanism involves the secretion of bioactive molecules that modulate the immune response and promote tissue repair.
- Other names
- 人脐带间充质干细胞制剂UC-MSC Preparation
Beyond the preview
Go deeper on human umbilical cord mesenchymal stem cell preparation (Shanghai Life Science & Technology).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on human umbilical cord mesenchymal stem cell preparation (Shanghai Life Science & Technology).